EDIT Editas Medicine, Inc.
Executive Summary
A mixed institutional cluster in Editas Medicine (EDIT) for Q4 2025 shows quant funds D.E. Shaw and Renaissance Technologies aggressively doubling their positions (combined +$3.7M), while mega-passive sellers BofA, Morgan Stanley, and Dimensional Fund Advisors trimmed or nearly exited, reducing holdings by ~$8.1M. The net effect is modest buying ($3.5M) against heavy selling, reflecting divergent views on the gene-editing biotech's near-term prospects.
Key Financial Metrics
Institutional Positions
Net institutional flow: $3.5M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | DOUBLED | +855.1% | $2.3M | $1.9M |
| Renaissance Technologies | DOUBLED | +138% | $6.2M | $1.8M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| BofA | NEAR_EXIT | -81.1% | $3.6M | -$3.2M |
| Morgan Stanley | TRIM | -37.6% | $3.8M | -$2.4M |
| Dimensional Fund Advisors | TRIM | -64% | $3.2M | -$2.5M |
Actionable Insight
The divergence between quant accumulation and passive selling suggests a catalyst-driven thesis (e.g., pipeline data readout) that quants are betting on but passive rebalancers are exiting. Watch for upcoming clinical trial results or partnership announcements that could resolve the directional uncertainty. The 45-day 13F lag means positions may have already been adjusted.
Key Facts
- 5 buyers added $3.5M net; 3 sellers reduced by $8.1M
- D.E. Shaw DOUBLED position (+855% shares to 1.11M, value $2.3M)
- Renaissance Technologies DOUBLED (+138% shares to 3.04M, value $6.2M)
- BofA nearly exited (-81% shares, value dropped from $3.6M to $397K)
- Morgan Stanley trimmed -38% shares (value from $3.8M to $1.4M)
- Dimensional Fund Advisors trimmed -64% shares (value from $3.2M to $688K)
- Cluster dominated by quant funds buying vs mega-passive funds selling
Financial Impact
Quant funds added ~$3.7M in new positions; mega-passive sellers reduced by ~$8.1M, for a net institutional outflow of ~$4.6M
Risk Factors
- 13F data is 45+ days stale; current positions may differ materially
- Selling by mega-passive funds (BofA, Morgan Stanley) could reflect index rebalancing, not fundamental view
- EDIT's small market cap ($243M) amplifies price impact of any institutional flow
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-EDIT-2025-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $2.49 awaiting T+5 | awaiting T+5 | — | — |
|
May 26, 2026
17d ago
|
424B5
| $3.57 $2.82 | ▲ +21.01% | ▲ +22.22% | — |
|
May 26, 2026
17d ago
|
8-K
| $3.57 $2.82 | ▲ +21.01% | ▲ +22.22% | — |
|
May 26, 2026
18d ago
|
Press Release
| $3.08 $3.34 | ▼ −8.44% | ▼ −7.36% | — |
|
May 26, 2026
18d ago
|
8-K
| $3.08 $3.34 | ▲ +8.44% | ▲ +7.36% | — |
|
May 26, 2026
18d ago
|
424B5
| $3.08 $3.34 | ▼ −8.44% | ▼ −7.36% | — |
|
May 26, 2026
18d ago
|
Press Release
| $3.08 $3.34 | ▼ −8.44% | ▼ −7.36% | — |
|
May 26, 2026
18d ago
|
Press Release
| $3.08 $2.82 | ▼ −8.44% | ▼ −9.65% | — |
|
May 14, 2026
4w ago
|
8-K
| $2.85 $2.67 | ▼ −6.32% | ▼ −5.60% | — |
|
May 14, 2026
4w ago
|
Press Release
| $2.85 $2.67 | ▼ −6.32% | ▼ −5.60% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access